Oncology
Revealing the molecular mechanism of tumor development and identifying the matching inhibitory candidates is one important area within the cancer research.
The tumor diversity is extremely high. Therefore, cancer research belongs to the high variant research areas with manifold scientific approaches.
To match this challenge, we offer you a unique diversity of products for your oncology research and development in the academic and pharmaceutical field.
Click on the organs and learn more about cancer types
General information
Oncologists focus on the diagnosis, therapy and follow-up of cancer.
Cancer is a class of diseases in which cells start to divide uncontrollably and invade other tissues. Cancer cells can spread to other parts of the body via the blood and lymphatic system. Under physiological conditions, cell proliferation is tightly controlled by many mechanisms. In addition, the immune system is able to recognize and destroy cancer cells. If these mechanisms fail or the immune system cannot effectively destroy the cells, it can lead to a malignant tumor. Theoretically, a malignant neoplasm can occur everywhere, but there are cancers that are more often than others. For men it is the prostate and in women it is the mammary gland.
Relevant products for oncology research
Name | Price | |||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Anti-PURA antibody (STJ191542) | Login | Anti-PURA antibody (STJ191542) | ||||||||||||||||
|
||||||||||||||||||
Anti-PURB antibody (STJ191543) | Login | Anti-PURB antibody (STJ191543) | ||||||||||||||||
|
||||||||||||||||||
Anti-MTIF2 antibody (450-530 aa) (STJ191551) | Login | Anti-MTIF2 antibody (450-530 aa) (STJ191551) | ||||||||||||||||
|
||||||||||||||||||
Anti-SART1 antibody (STJ191564) | Login | Anti-SART1 antibody (STJ191564) | ||||||||||||||||
|
||||||||||||||||||
Anti-LSM2 antibody (40-120 aa) (STJ191565) | Login | Anti-LSM2 antibody (40-120 aa) (STJ191565) | ||||||||||||||||
|
||||||||||||||||||
Anti-UBQLN2 antibody (STJ191566) | Login | Anti-UBQLN2 antibody (STJ191566) | ||||||||||||||||
|
||||||||||||||||||
Anti-USP35 antibody (STJ191577) | Login | Anti-USP35 antibody (STJ191577) | ||||||||||||||||
|
||||||||||||||||||
Anti-BAP1 antibody (150-230 aa) (STJ191583) | Login | Anti-BAP1 antibody (150-230 aa) (STJ191583) | ||||||||||||||||
|
||||||||||||||||||
Anti-UBA6 antibody (STJ191587) | Login | Anti-UBA6 antibody (STJ191587) | ||||||||||||||||
|
||||||||||||||||||
Anti-UBAP1 antibody (STJ191588) | Login | Anti-UBAP1 antibody (STJ191588) | ||||||||||||||||
|
||||||||||||||||||
Anti-UBE2D1 antibody (STJ191590) | Login | Anti-UBE2D1 antibody (STJ191590) | ||||||||||||||||
|
||||||||||||||||||
Anti-UBE2S antibody (STJ191602) | Login | Anti-UBE2S antibody (STJ191602) | ||||||||||||||||
|
||||||||||||||||||
Anti-VANGL2 antibody (STJ191621) | Login | Anti-VANGL2 antibody (STJ191621) | ||||||||||||||||
|
||||||||||||||||||
Anti-BNIP1 antibody (STJ191625) | Login | Anti-BNIP1 antibody (STJ191625) | ||||||||||||||||
|
||||||||||||||||||
Anti-SYT7 antibody (STJ191495) | Login | Anti-SYT7 antibody (STJ191495) | ||||||||||||||||
|
||||||||||||||||||
Anti-TBC1D2 antibody (STJ191502) | Login | Anti-TBC1D2 antibody (STJ191502) | ||||||||||||||||
|
||||||||||||||||||
Anti-TLX1 antibody (STJ191504) | Login | Anti-TLX1 antibody (STJ191504) | ||||||||||||||||
|
||||||||||||||||||
Anti-TLX3 antibody (STJ191505) | Login | Anti-TLX3 antibody (STJ191505) | ||||||||||||||||
|
||||||||||||||||||
Anti-TCAP antibody (STJ191507) | Login | Anti-TCAP antibody (STJ191507) | ||||||||||||||||
|
||||||||||||||||||
Anti-TM2D1 antibody (STJ191517) | Login | Anti-TM2D1 antibody (STJ191517) | ||||||||||||||||
|
||||||||||||||||||
Anti-TRAPPC6B antibody (STJ191522) | Login | Anti-TRAPPC6B antibody (STJ191522) | ||||||||||||||||
|
||||||||||||||||||
Anti-TCF20 antibody (STJ191530) | Login | Anti-TCF20 antibody (STJ191530) | ||||||||||||||||
|
||||||||||||||||||
Anti-BTF3 antibody (120-200 aa) (STJ191532) | Login | Anti-BTF3 antibody (120-200 aa) (STJ191532) | ||||||||||||||||
|
||||||||||||||||||
Anti-EBF3 antibody (50-130 aa) (STJ191533) | Login | Anti-EBF3 antibody (50-130 aa) (STJ191533) | ||||||||||||||||
|
||||||||||||||||||
Anti-TAF1L antibody (STJ191536) | Login | Anti-TAF1L antibody (STJ191536) | ||||||||||||||||
|